ArcaScience raises $7M to expand AI benefit risk platform in drug development - SiliconANGLE

ArcaScience raises $7M to transform drug development with AI benefit-risk intelligence

ArcaScience, the AI healthtech startup setting a new standard for benefit-risk evaluation to make better, safer drugs, has announced a $7 million seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies.

ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk Evaluation

What You Should Know:  – ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies. This marks the company’s first institutional funding round, following a €1.3 million pre-seed raise. – The new funds will be used to expand operations in the U.S. and U.K., launch the company’s first patient…

ArcaScience raises $7M to expand AI benefit risk platform in drug development - SiliconANGLE

French artificial intelligence healthtech startup ArcaScience SAS revealed today that it has raised $7 million in new funding to expand into the U.S. and the U.K., launch a patient-facing solution for pediatric brain cancer and dermatological diseases,and hire a chief medical officer. Founded in 2018, ArcaScience is an AI-first healthtech startup that has been built […] The post ArcaScience raises $7M to expand AI benefit risk platform in drug d…